In 2002, the Ministry of Health and Social Welfare and TFDA worked with Management Sciences for Health's (MSH) Strategies for Enhancing Access to Medicines Program, with funding from the Bill & Melinda Gates Foundation, to pilot an innovative private sector drug seller program to transform the DLDB into government-accredited drug dispensing outlets (ADDO -- Duka la Dawa Muhinu in Kiswahili.
The computerized drug-dispensing histories contain information concerning dispensed drug, dispensing date, prescriber, amount dispensed, prescribed dose regimen, and estimated duration of use.
Prescription drug monitoring programs (PDMPs) often referred to as PDMPs or PMPs are state housed data systems that collect controlled substance prescription drug dispensing information as dictated by their state legislation.
Tanzania's accredited drug dispensing outlet (ADDO) program includes dispenser training, enforcement of standards, and the legal right to sell selected antimicrobials.
Data available for each retail pharmacy claim include the drug dispensed, dispensing date, quantity dispensed, and number of days supplied.
Data available for each retail pharmacy claim include the drug dispensed (in National Drug Code [NDC] format), dispensing date, quantity dispensed, and number of days of therapy supplied.
The PBS database captures all subsidized drug formulations, cost and amount of dispensing and period of drug dispensed by pharmacists for patients used at home [ 29].
Tanzania implemented the accredited drug dispensing outlet (ADDO) program in 2003 [ 1– 3].
Tanzania introduced the accredited drug dispensing outlet (ADDO) program more than a decade ago.
The accredited drug dispensing outlet (ADDO) program combines extensive training, business incentives, authorization to dispense a limited list of antimicrobials and other medicines to treat common conditions, regulatory enforcement of practice standards, and efforts to affect customer demand [ 11].
The National Malaria Control Program identified the accredited drug dispensing outlet (ADDO) program as a private sector mechanism to supplement the distribution of subsidized artemisinin-based combination therapies (ACTs) from public facilities and increase access to the first-line antimalarial in rural and underserved areas.
